Clinical Trial Update: A Safety and Efficacy Study of a Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) in Patients With Hemophilia B [Phase 2, Phase 3]

View source ↗

Summary

This document reports results from Phase 2 and Phase 3 trials evaluating a recombinant Factor IX–albumin fusion protein (rIX-FP) for Hemophilia B, focusing on s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• IdElvion
• recombinant coagulation factor IX–albumin fusion protein (rIX-FP) (recombinant coagulation factor IX–albumin fusion protein)

Snippet

Sponsor: CSL Behring | Conditions: Hemophilia B | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2016-05-09